THE HEALTH EQUITY STRATEGIES GROUP, LLC

Lobbying for TRAVERE THERAPEUTICS · Pharmaceutical company

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Nov 20, 2025

Income

$16,000.00

What the client paid this registrant for the period.

Client based in

California

Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 4

Health Issues

Rare kidney disease

Medical/Disease Research/Clinical Labs

Rare kidney disease

Medicare/Medicaid

Rare kidney disease

Pharmacy

Rare kidney disease

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.